On December 6, 2024, Michael Harrington, a Director at Inotiv Inc (NOTV, Financial), purchased 10,000 shares of the company, as reported in the SEC Filing. Following this transaction, the insider now holds a total of 37,500 shares in the company.
Inotiv Inc is a contract research organization that provides nonclinical and analytical drug discovery and development services. The company supports pharmaceutical, biotechnology, and medical device companies in their research and development efforts.
The insider's recent purchase is part of a broader trend within the company. Over the past year, there have been four insider buys and zero insider sells, indicating a positive sentiment among the company's insiders.
On the day of the purchase, shares of Inotiv Inc were trading at $3.98, giving the stock a market cap of $120.189 million. The company's GF Value is estimated at $4.88, resulting in a price-to-GF-Value ratio of 0.82. This suggests that the stock is fairly valued according to its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
